Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Updated Meta-analysis of the Association Between CYP2E1 RsaI/PstI Polymorphisms and Lung Cancer Risk in Chinese Population

  • Wang, Ya-Dong (Department of Toxicology, Henan Center for Disease Control and Prevention) ;
  • Yang, Hai-Yan (Department of Epidemiology and Health Statistics, School of Public Health, Zhengzhou University) ;
  • Liu, Jing (Department of Epidemiology and Health Statistics, School of Public Health, Zhengzhou University) ;
  • Wang, Hai-Yu (Department of Toxicology, Henan Center for Disease Control and Prevention)
  • Published : 2014.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: A number of studies have reported relationships of CYP2E1 RsaI/PstI polymorphisms with susceptibility to lung cancer in Chinese population. However, the epidemiologic results have been conflictive rather than conclusive. The purpose of this study was to address the associations of CYP2E1 RsaI/PstI polymorphisms with lung cancer risk in Chinese population comprehensively. Materials and Methods: Systematic searches were conducted in the PubMed, Science Direct, Elsevier, CNKI and Chinese Biomedical Literature Databases. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to estimate the strength of association. Results: Overall, we observed a decreased lung cancer risk among subjects carrying CYP2E1 RsaI/PstI c1/c2 and c1/c2+c2/c2 genotypes (OR=0.76, 95%CI: 0.64-0.90 and OR=0.78, 95%CI: 0.66-0.93, respectively), as compared with subjects carrying the c1/c1 genotype. In subgroup analysis, we observed a decreased lung cancer risk among c1/c2 carriers in hospital-based studies (OR=0.81, 95%CI: 0.68-0.98) and among carriers with c1/c2 and c1/c2+c2/c2 genotypes in population-based studies(OR=0.57, 95%CI: 0.42-0.79 and OR=0.58, 95%CI: 0.43-0.79, respectively), as compared with subjects carrying the c1/c1 genotype. Limiting the analysis to studies with controls in Hardy-Weinberg equilibrium (HWE), we similarly observed a decreased lung cancer risk among c1/c2 and c1/c2+c2/c2 carriers (OR=0.73, 95%CI: 0.60-0.88 and OR=0.73, 95%CI: 0.60-0.88, respectively), as compared with c1/c1. Conclusions: Our results suggested that CYP2E1 RsaI/PstI c1/c2 and c1/c2+c2/c2 variants might be a protective factor for developing lung cancer in Chinese population. Further well-designed studies with larger sample size are required to verify our findings.

Keywords

References

  1. Agundez JA (2008). Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab, 9, 520-31. https://doi.org/10.2174/138920008784892083
  2. Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
  3. Cao L, Lin J, He B, et al (2013). A regulatory variant in CYP2E1 affects the risk of lung squamous cell carcinoma. Tumour Biol, DOI 10.1007/s13277-013-1063-x.
  4. Chen S, Yu S, Chen Q, et al (2002). A case-control study of the impact of CYP2E1 RsaI polymorphism on the risk of lung cancer. J Guangdong College of Pharmacy, 18, 220-4.
  5. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. https://doi.org/10.1016/0197-2456(86)90046-2
  6. Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
  7. Gu Y, Zhang Z, Zhang S, et al (2007). Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility. Zhonghua Yi Xue Za Zhi, 87, 3064-8.
  8. Guo S, Li X, Gao M, et al (2012). Synergistic association of PTGS2 and CYP2E1 genetic polymorphisms with lung cancer risk in northeastern Chinese. PLoS One, 7, 39814. https://doi.org/10.1371/journal.pone.0039814
  9. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559-65. https://doi.org/10.1093/oxfordjournals.jbchem.a123619
  10. Huang Y, Wang Q, Zhu L, Zhang Y (2000). Relationship between cytochrome P450 2E1 Genetic Polymorphism and Lung Cancer in Chinese Han subjects. J Clin Pharmacol, 16, 350-2.
  11. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  12. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y (2005). NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med, 7, 463-78. https://doi.org/10.1097/01.gim.0000177530.55043.c1
  13. Lakkakula S, Maram R, Munirajan AK, et al (2013). Functional PstI/RsaI polymorphisms in the CYP2E1 gene among south Indian populations. Asian Pac J Cancer Prev, 14, 179-82. https://doi.org/10.7314/APJCP.2013.14.1.179
  14. Li D, Zhou Q, Guo Z, et al (2008). Association between genetic polymorphisms of CYP2E1 and lung cancer susceptibility:a case control study. Journal of Third Military Medical University, 30, 1231-4.
  15. Li W, Lai B, Zhan X (2004). The relationship between genetic polymorphism of metabolizing enzymes and the genetic susceptibility to lung cancer. Chinese J Epidemiol, 25, 1042-5.
  16. Li W, Yue W, Zhang L, et al (2012). Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients. Lung, 190, 91-8. https://doi.org/10.1007/s00408-011-9338-8
  17. Li Z, Tan W, Shao K, Zhang L, Lin D (2000). Susceptibility to lung cancer in Chinese is associated with genetic polymorphism in cytochrome P4502E1. Chin J Oncol, 22, 5-7.
  18. Liang G, Pu Y, Yin L (2004). Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Hereditas, 26, 584-8.
  19. Liu H, Li HY, Chen HJ, et al (2013). EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis. Tumour Biol, 34, 155-63. https://doi.org/10.1007/s13277-012-0523-z
  20. Liu H, Su Y, Chen R, Wei J (2010). Study on the relationship between genetic polymorphism of human cytochrome P450 2E l gene and susceptibility to Xuanwei's lung cancer. J Mod Lab Med, 25, 23-6.
  21. Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 population-based cancer registries. Asian Pac J Cancer Prev, 15, 1471-5. https://doi.org/10.7314/APJCP.2014.15.3.1471
  22. Liu Y, Meng XW, Zhou LY, et al (2009). Genetic polymorphism and mRNA levels of cytochrome P450IIE1 and glutathione S-transferase P1 in patients with alcoholic liver disease in different nationalities. Hepatobiliary Pancreat Dis Int, 8, 162-7.
  23. Lucas D, Menez C, Girre C, et al (1995). Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics, 5, 298-304. https://doi.org/10.1097/00008571-199510000-00005
  24. Luqman M, Javed MM, Daud S, et al (2014). Risk factors for lung cancer in the Pakistani population. Asian Pac J Cancer Prev, 15, 3035-9. https://doi.org/10.7314/APJCP.2014.15.7.3035
  25. Marchand LL, Wilkinson GR, Wilkens LR (1999). Genetic and dietary predictors of CYP2E1 activity: a phenotyping study in Hawaii Japanese using chlorzoxazone. Cancer Epidemiol Biomarkers Prev, 8, 495-500.
  26. Persson I, Johansson I, Lou YC, et al (1999). Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients. Int J Cancer, 81, 325-9. https://doi.org/10.1002/(SICI)1097-0215(19990505)81:3<325::AID-IJC2>3.0.CO;2-S
  27. Phukan RK, Saikia BJ, Borah PK, et al (2014). Role of household exposure, dietary habits and glutathione S-Transferases M1, T1 polymorphisms in susceptibility to lung cancer among women in Mizoram India. Asian Pac J Cancer Prev, 15, 3253-60. https://doi.org/10.7314/APJCP.2014.15.7.3253
  28. Qu Y, Shi Y, Zhang l, et al (1998). Cytochrome P450 2E1 Genetic Polymorphism and Non-smoking Female Lung Cancer Risk. Carcinogenesis Teratogenesis and Mutagenesis, 10, 355-8.
  29. Salanti G, Amountza G, Ntzani EE, Ioannidis JP (2005). Hardy-Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet, 13, 840-8. https://doi.org/10.1038/sj.ejhg.5201410
  30. Shah PP, Singh AP, Singh M, et al (2008). Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res, 639, 1-10. https://doi.org/10.1016/j.mrfmmm.2007.10.006
  31. Shahriary GM, Galehdari H, Jalali A, et al (2012). CYP2E1*5B, CYP2E1*6, CYP2E1*7B, CYP2E1*2, and CYP2E1*3 allele frequencies in Iranian populations. Asian Pac J Cancer Prev, 13, 6505-10. https://doi.org/10.7314/APJCP.2012.13.12.6505
  32. Shi Y, Zhou X, Zhou Y, Ren X (2002). Analysis of CYP2E1, GSTM1 genetic polymorphisms in relation to human lung cancer and esophageal carcinoma. J Huazhong Univ Sci Technolog Med Sci, 31, 14-7.
  33. Shields PG, Harris CC (2000). Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. J Clin Oncol, 18, 2309-15. https://doi.org/10.1200/JCO.2000.18.11.2309
  34. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA Cancer J Clin, 63, 11-30. https://doi.org/10.3322/caac.21166
  35. Soya SS, Padmaja N, Adithan C (2005). Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese. Asian Pac J Cancer Prev, 6, 315-9.
  36. Su XL, Bin B, Cui HW, Ran MR (2011). Cytochrome P450 2E1 RsaI/PstI and DraI polymorphisms are risk factors for lung cancer in Mongolian and Han populations in Inner Mongolia. Chin J Cancer Res, 23, 107-11. https://doi.org/10.1007/s11670-011-0107-2
  37. Tan W, Wu J, Tang H, Lin D (2001). Expression of cytochrome P4502E1 in human liver: Relationship between genotype and phenotype in Chinese. Sci China C Life Sci, 44, 356-64. https://doi.org/10.1007/BF02879602
  38. Ulusoy G, Arinc E, Adali O (2007). Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol, 81, 711-8. https://doi.org/10.1007/s00204-007-0200-y
  39. Wang D, Chen S, Wang B, Zhou W (2006). A case-control study on the impact of cytochrome P450 2E1 and 1A1 gene polymorphisms on the risk of lung cancer of the Han nationality in Guangzhou district. Chin J Lung Cancer, 9, 497-501.
  40. Wang F, Yang H (2010a). Meta-analysis of relationship between the polymorphism of cytochrome P4502E1 RsaI/PstI and susceptibility of lung cancer in Chinese populations. Chinese J Prev Med, 44, 553-4.
  41. Wang H, Song K, Chen Z, Yu Y (2013). Poor metabolizers at the cytochrome P450 2C19 loci is at increased risk of developing cancer in Asian populations. PLoS One, 8, 73126. https://doi.org/10.1371/journal.pone.0073126
  42. Wang J, Deng Y, Li L, et al (2003). Association of GSTM1, CYP1A1 and CYP2E1 genetic polymorphisms with susceptibility to lung adenocarcinoma: a case-control study in Chinese population. Cancer Sci, 94, 448-52. https://doi.org/10.1111/j.1349-7006.2003.tb01463.x
  43. Wang SL, Lee H, Chen KW, et al (1999). Cytochrome P4502E1 genetic polymorphisms and lung cancer in a Taiwanese population. Lung Cancer, 26, 27-34. https://doi.org/10.1016/S0169-5002(99)00070-7
  44. Wang Y, Yang H, Li L, et al (2010b). Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer, 46, 758-64. https://doi.org/10.1016/j.ejca.2009.12.010
  45. Watanabe J, Hayashi S, Nakachi K, et al (1990). PstI and RsaI RFLPs in complete linkage disequilibrium at the CYP2E gene. Nucleic Acids Res, 18, 7194.
  46. Ye W, Chen S, Chen Q, Zhang D, Cai X (2006). Association of CYP2E1 polymorphism and serum selenium level with risk of human lung cancer. Tumor, 26, 450-2.
  47. Zhan P, Wang J, Zhang Y, et al (2010). CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer, 69, 19-25. https://doi.org/10.1016/j.lungcan.2009.09.001
  48. Zhao P, Dai M, Chen W, Li N (2010). Cancer trends in China. Jpn J Clin Oncol, 40, 281-5. https://doi.org/10.1093/jjco/hyp187
  49. Zhou HF, Feng X, Zheng BS, Qian J, He W (2013). A meta-analysis of the relationship between glutathione S-transferase T1 null/presence gene polymorphism and the risk of lung cancer including 31802 subjects. Mol Biol Rep, 40, 5713-21. https://doi.org/10.1007/s11033-013-2674-4
  50. Zou L, Lv B, Zhang X, et al (2004). Effect of CYP2E1 polymorphism on DNA stability and lung cancer susceptibility. J Environmental Occupational Medicine, 21, 81-3.

Cited by

  1. Significant Genotype Difference in the CYP2E1 PstI Polymorphism of Indigenous Groups in Sabah, Malaysia with Asian and Non-Asian Populations vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7377
  2. Genetic susceptibility of lung cancer in Chinese population: An overview of systematic reviews and meta-analyses vol.10, pp.3, 2017, https://doi.org/10.1111/jebm.12269
  3. Acarbose Use and Liver Injury in Diabetic Patients With Severe Renal Insufficiency and Hepatic Diseases: A Propensity Score-Matched Cohort Study vol.9, pp.1663-9812, 2018, https://doi.org/10.3389/fphar.2018.00860